is tirzepatide on shortage Eli Lilly's Weight-Loss Drug Zepbound Officially Over: FDA FDA says shortage of popular

p=0.002) (36)

Fix: Write the concentration on the vial immediately after reconstitution

Reconstituted solutions remain stable for approximately 2-3 weeks under these conditions

Revenue target : OneSource aims to achieve $400 million in annual revenue within the next three years, with semaglutide as a key contributor

doi: 10.3389/fonc.2026.1745285 Received 30 December 2025 Revised 18 December 2025 Accepted 14 January 2026 Published 11 February 2026 Volume 16 - 2026 Edited by Rohit Upadhyay, Tulane University, United States Reviewed by Seydi Ykm, Namik Kemal University, Trkiye Fatima Zahra Jawhari, Institut Suprieur des Professions Infirmires et Techniques de Sant, Morocco Updates Copyright 2026 Kmail